Literature DB >> 24686741

Antischistosomal versus antiandrogenic properties of aryl hydantoin Ro 13-3978.

Chunkai Wang1, Qingjie Zhao1, Jaeki Min1, Sakthivel Muniyan1, Mireille Vargas1, Xiaofang Wang1, Yuxiang Dong1, R Kiplin Guy1, Ming-Fong Lin1, Jennifer Keiser1, Jonathan L Vennerstrom2.   

Abstract

In the early 1980s, the antischistosomal aryl hydantoin Ro 13-3978 (AH01), a close structural analogue of the androgen receptor antagonist nilutamide, was discovered. Administration of 100 mg/kg oral doses of AH01 to mice infected with adult and juvenile Schistosoma mansoni produced 95% and 64% total worm burden reductions, confirming its high activity against adult worms, and showing that AH01 is also effective against juvenile infections. AH01 had no measureable interaction with the androgen receptor in a ligand competition assay, but it did block dihydrotestosterone-induced cell proliferation in an androgen-dependent human prostate cancer cell line. For AH01, nilutamide, and three closely related aryl hydantoin derivatives, there was no correlation between antischistosomal activity and androgen receptor interaction. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24686741      PMCID: PMC4047746          DOI: 10.4269/ajtmh.14-0029

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  19 in total

1.  Molecular characterisation of a NADH ubiquinone oxidoreductase subunit 5 from Schistosoma mansoni and inhibition of mitochondrial respiratory chain function by testosterone.

Authors:  M R Fantappié; A Galina; R Luís de Mendonça; D R Furtado; W E Secor; D G Colley; R Corrêa-Oliveira; G Freeman; A J Tempone; L Lannes de Camargo; D F Rumjanek
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

2.  [Efficacy of schistosomicide derivatives, appreciation with electronic microscopy experimental model (author's transl)].

Authors:  E Forget; H Félix; M J Notteghem; N Léger
Journal:  Bull Soc Pathol Exot Filiales       Date:  1982 Mar-Apr

3.  In vitro effects of hypothalamic-pituitary-adrenal axis (HPA) hormones on Schistosoma mansoni.

Authors:  J Morales-Montor; F Mohamed; A M Ghaleb; S Baig; C Hallal-Calleros; R T Damian
Journal:  J Parasitol       Date:  2001-10       Impact factor: 1.276

4.  Establishment and characterization of androgen-independent human prostate cancer LNCaP cell model.

Authors:  Tsukasa Igawa; Fen-Fen Lin; Ming-Shyue Lee; Dev Karan; Surinder K Batra; Ming-Fong Lin
Journal:  Prostate       Date:  2002-03-01       Impact factor: 4.104

5.  Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interaction, and transcription activation.

Authors:  J Veldscholte; C A Berrevoets; A O Brinkmann; J A Grootegoed; E Mulder
Journal:  Biochemistry       Date:  1992-03-03       Impact factor: 3.162

6.  Mechanism of antiandrogen action: key role of hsp90 in conformational change and transcriptional activity of the androgen receptor.

Authors:  Virginie Georget; Béatrice Térouanne; Jean-Claude Nicolas; Charles Sultan
Journal:  Biochemistry       Date:  2002-10-01       Impact factor: 3.162

7.  Determination of the dissociation constant of a weak acid using a dissolution rate method.

Authors:  J B Hansen; O Hafliger
Journal:  J Pharm Sci       Date:  1983-04       Impact factor: 3.534

8.  Characteristics of the biphasic action of androgens and of the potent antiproliferative effects of the new pure antiestrogen EM-139 on cell cycle kinetic parameters in LNCaP human prostatic cancer cells.

Authors:  Y de Launoit; R Veilleux; M Dufour; J Simard; F Labrie
Journal:  Cancer Res       Date:  1991-10-01       Impact factor: 12.701

9.  The proliferative effect of "anti-androgens" on the androgen-sensitive human prostate tumor cell line LNCaP.

Authors:  N Olea; K Sakabe; A M Soto; C Sonnenschein
Journal:  Endocrinology       Date:  1990-03       Impact factor: 4.736

Review 10.  The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer).

Authors:  Piero Olliaro; Petra Delgado-Romero; Jennifer Keiser
Journal:  J Antimicrob Chemother       Date:  2014-01-02       Impact factor: 5.790

View more
  3 in total

Review 1.  Chemotherapy for human schistosomiasis: how far have we come? What's new? Where do we go from here?

Authors:  Godwin Akpeko Dziwornu; Henrietta Dede Attram; Samuel Gachuhi; Kelly Chibale
Journal:  RSC Med Chem       Date:  2020-04-06

2.  Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal.

Authors:  Jennifer Keiser; Gordana Panic; Mireille Vargas; Chunkai Wang; Yuxiang Dong; Nagsen Gautam; Jonathan L Vennerstrom
Journal:  J Antimicrob Chemother       Date:  2015-02-16       Impact factor: 5.790

3.  Revisiting the SAR of the Antischistosomal Aryl Hydantoin (Ro 13-3978).

Authors:  Chunkai Wang; Qingjie Zhao; Mireille Vargas; Jeremy O Jones; Karen L White; David M Shackleford; Gong Chen; Jessica Saunders; Alice C F Ng; Francis C K Chiu; Yuxiang Dong; Susan A Charman; Jennifer Keiser; Jonathan L Vennerstrom
Journal:  J Med Chem       Date:  2016-11-28       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.